Tausi Insider

Mid-cap Neurocrine Biosciences (NASDAQ: NBIX) continued its uptrend Thursday, along with the market-wide broad rally. MarketBeat.com - MarketBeat The stock came within a penny of Tuesday’s all-time high of $125.99 before pulling back. Nonetheless, the San Diego-based biotech finished the session with a gain of $1.40, or 1.15%, at $123.22. Trading volume was lighter than average. The company develops and commercializes pharmaceutical treatments for neurological, endocrine, and psychiatric conditions. On November 1, it easily trounced Wall Street’s third-quarter expectations. Earnings came in at $1.08 per share, way ahead of analysts’ consensus, calling for $0.81 a share. That marked a 69% year-over-year increase. Revenue was up 31% to $387.9 million, beating forecasts of $377 million. In the past five quarters, revenue grew between 15% and 31%, with the latter number being a steady growth rate for...

2022 has been a very difficult year for investors as the stock market (SPY) has tumbled into bear market territory. Thus, the strategies that worked so well in 2021 are getting crushed. Add inflation and a hawkish Fed to the mix and you understand why the downward pressure persists. And yet some investors are making money in this market if they employ the right strategies. That is what you will find in this article detailing the 100 Best Stocks for November 2022. Get full details below. shutterstock.com - StockNews We enjoyed a record turnout for this live event Wednesday afternoon, where I shared our most profitable solution for investors. This includes details on our 100 best stocks for November...and into 2023. Click Here to Watch Now > The revolutionary trading system shared in the presentation actually consists of 10 different “black box” trading strategies each with precisely 10 stocks ea...

The latest inflation report has raised the odds of the Fed slowing down on its aggressive rate hikes, which might bode well for the tech sector. Moreover, demand for software goods and services remains robust amid the rapid digital transformation. Given the backdrop, quality software stock Salesforce (CRM) could be an ideal buy now. However, Bill.com Holdings (BILL) might be best avoided, given its bleak fundamentals. Keep reading…. shutterstock.com - StockNews The consumer price index increased 7.7% in October , lower than expected, raising hopes that the Fed might slow down the pace of its rate hike in the next meeting, which might bode well for the software sector. San Francisco Fed President Mary Daly said, "Stepping down is an appropriate thing to think about." The tech-heavy NASDAQ Composite has gained 6.1% over the past week. Moreover, according to Gartner, enterprise software sp...

Will the next bull market in stocks resemble the previous one? Don’t count on it. As major North American benchmark indexes rise from recent lows in October – punctuated by Thursday’s strong rally based on data that showed easing U.S. inflation in October – it is only natural to ponder whether the worst of this year’s sell-off is behind us. There are still many threats hanging over the market, of course. Inflation remains a threat, central banks will likely continue to raise interest rates, there is a looming recession and corporate profits are slowing. Nevertheless, observers are now wondering what themes might drive the next sustained rally and what leaders might emerge. There is a significant payoff for anyone who gets it right. Stocks that tap into sweeping secular trends can produce stunning long-term gains, in some cases not only leading the stock market over a number of years, but defining it. Think of technology stocks in the 1990s, the commodities boom prior to the 2008-09 f...

Medical device maker DexCom (NASDAQ: DXCM) has been trading in a fairly tight range recently, holding gains from the company’s third-quarter report in late October.  MarketBeat.com - MarketBeat The stock is up 16.33% in the past month. Even before the 19% gap-up following the earnings report, DexCom was already beginning to trend higher.  In the past three months, DexCom has advanced 31.41%. It’s not the top performer within the medical device industry in the past 12 months, however. A large cap with top performance is Abiomed (NASDAQ: ABMD). Smaller medical gear makers with outstanding price action include TransMedics Group (NASDAQ: TMDX ) and Lantheus (NASDAQ: LNTH) . Numerous small companies have also posted excellent price performance in the past year, making the entire sub-industry a rising leader within the broader healthcare sector.  Fellow large caps Medtronic (NYSE: MDT) , Stryker (NYSE:...

The October CPI came in below expectations and fueled an explosive rally on Wall Street with the S&P 500 (SPY) up by more than 4% and bonds also shooting higher. In essence, the odds of a soft landing increase if inflation can turn lower and then keep moving lower. This development would also likely cause the Fed to slow its pace of hikes. Of course, the next big question, assuming that inflation has peaked, is how low will it fall? Will it plateau at higher levels or will it fall back to the 2% range? Today's commentary will explore these questions and the implications for our portfolio. Read on below to find out more…. shutterstock.com - StockNews (Please enjoy this updated version of my weekly commentary originally published November 11 th , 2022 in the POWR Stocks Under $10 newsletter ). Over the last week, the S&P 500 ( SPY ) is up by 6.4%. Following the FOMC, stocks were pretty c...

Following the midterm elections, it's clear that voters are rejecting extremist candidates on both sides, while moderates and independents are ascending. This article discusses some takeaways from the election and 3 stocks that should prosper - Walmart (WMT), Expedia (EXPE), and Northrop Grumman (NOC). shutterstock.com - StockNews It’s interesting that even as the world gets more connected, it seems to be getting more unpredictable. We have had a string of recent elections with outcomes that went contrary to expectations, and the latest midterm elections are no exception. In essence, there were expectations of a massive ‘red wave’ which would propel Republicans to control of the House and Senate. Instead, it looks more like a ‘red ripple’ as Republicans are likely to take control of the House with a small majority but fail to win the Senate. They also made gains in states like Florida and the ...

Bear markets can be brutal and messy. They often don't end until testing the resolve of investors. And even for bears, they aren't easy affairs as evidenced by the stock market's 7% pop following a soft CPI report. They also are necessary and healthy as they cleanse the financial system and economy of fraud and bad actors as we are seeing with the FTX blowup. In terms of the economy, certain parts of the economy are under pressure, but there's nothing rotten systemically or signs of excess leverage which would cause a cascade lower like 2008. In today's commentary, I want to talk about the inflation report and put it in context within today’s stock market (SPY). Then, I want to touch on the various blowups that we've seen during the bear market and my gameplan for taking advantage of the opportunities created amid the wreckage. Read on below to find out more…. shutterstock.com - StockNews ...

U.S. crude stocks fell by more than 5 million barrels in the most recent week, while fuel stocks rose as refiners boosted output to deal with high demand and low inventories. Crude inventories fell by 5.4 million barrels in the week ended Nov. 11 to 435.4 million barrels, the U.S. Energy Information Administration said on Wednesday, compared with expectations in a Reuters poll for a 440,000-barrel drop. “The drawdown in crude supplies is substantial. The crude supply is still very tight, heating oil supply is still below average,” said Phil Flynn, senior analyst at Price Futures Group in Chicago. “My gut feeling is it’s a very supportive report, it shows supplies are very tight.” Refinery crude runs picked up in the most recent week, rising by 63,000 barrels per day to bring refinery utilization rates to 92.9 per cent of overall capacity, up 0.8 percentage points. Fuel stocks rose across the board, a salve for end-users worried about low inventories that have persisted for several mo...

The Dow Jones Industrial stocks (DIA) have barely budged this year even with so many stocks cratering in the stock carnage of 2022. Look for the mighty Dow to eventually fall fast as 2023 begins. shutterstock.com - StockNews Stocks have certainly bounced strongly off their recent lows. NASDAQ 100 (QQQ) is now up just over 12% from the October lows. S&P 500 (SPY) added on almost 15% in the same time frame. The Dow Jones Industrials (DIA) has been the star performer, gaining nearly 18% in the past two months. Lower interest rates and not so terrible earnings have certainly provided some fuel for the recent red-hot rally. Now that earnings season is winding down and rates are finding a floor, look for stocks to have trouble gaining ground from here. This is especially true for the Dow 30 stocks which have gotten too far ahead of themselves on a comparative and actual basis. Plus, the Dow is about...

There are preps all around for the holiday season. Consumers eye discounts, and retail stores increase their in-store workforce. With inflation finally showing signs of slowing down and consumer demand remaining robust, it could be wise to pick up fundamentally strong retail stocks Walmart (WMT), Dollar General (DG), Dillard's (DDS), Torrid Holdings (CURV), and J.Jill (JILL) to capitalize on the holiday retail sales boom. Continue reading…. shutterstock.com - StockNews The Fed has aggressively increased interest rates this year to tame the multi-decade-high inflation. After six consecutive interest rate hikes, inflation seems to have started cooling off, as evidenced by October’s lower-than-expected Consumer Price Index (CPI). Moreover, Federal Reserve Vice Chair Lael Brainard indicated that the central bank could soon slow down the pace of its interest rate increases. According to the Nationa...

We are approaching that time of year when the stock market gets into a holiday mood triggering a Santa Claus rally into the new year. With the S&P 500 index (NYSEARCA: SPY) trading down (-17%) and Nasdaq (NASDAQ: QQQ) down a naughty (-29%) for the year, investors are left to ponder if markets have the wherewithal to stage a Santy Claus Rally. The biggest concern for the markets is rising interest rates. The U.S. Federal Reserve will have its final meeting for the year concluding on Dec. 14, 2022. They will determine the final interest rate hike and provide commentary and a question-and-answering session detailing their thoughts heading into next year. Leading up to the rate decision, there are two crucial economic reports and a slew of other factors to be aware of. Here’s what needs to happen for the Santa Claus rally to occur. MarketBeat.com - MarketBeat The Fed: Grinch or Santa? Will the ...